如果是转移性肝癌，就需要加入顺铂。
If the cancer is metastatic instead of primary, mitomycin and cisplatin are added.
目的探讨大肠癌伴转移性肝癌的门静脉的特点。
Objective To investigate the characteristic of portal vein in the colorectal cancer with liver metastasis.
目的：分析转移性肝癌应用放疗的疗效及预后因子。
Objective:To evaluate the efficacy of liver metastases cancer treated by radiotherapy, and investigate the prognostic factors.
目的探讨不明原发灶的转移性肝癌的诊断、治疗及预后。
Objective To investigate the diagnosis, treatment and prognosis of hepatic metastasis with unknown primary focal.
结论：康莱特联合化学药物动脉灌注治疗转移性肝癌有较好的疗效。
Conclusions: Kanglaite injection combined with chemical medicine through artery infusion has relatively better curative effects on hepatic metastasis carcinoma.
目的研究MSCT血管重建和双重化疗栓塞治疗转移性肝癌的效果。
AIM: To study the effect of MSCT vascular reconstruction and chemoembolization through portal vein and liver artery in patients with liver cancer metastases.
结论：糖尿病是影响转移性肝癌安全性及治疗疗效的一个重要因素。
Conclusion: Diabetes is an important factor that affects the security and curative effect of interventional therapy of metastatic cancer liver.
目的：探讨二维及彩色多普勒超声（CDFI）对转移性肝癌的诊断价值。
Objective: To explore the diagnostic value of color Doppler flow imaging(CDFI) in metastatic hepatic cancer(MHC).
转移性肝癌通常不选择肝移植，是因为这类病人手术后更易引起肿瘤转移。
Patients with liver tumors that have spread from other organs are not transplant candidates because the risk of post-transplant tumors developing elsewhere in the body is too high.
转移性肝癌的始增时间与原发性肝癌有显著的统计学差异（P＜0.05）。
The initiation time of enhancement in liver metastasis was significantly different compared to primary liver cancers (P<0.05) .
目的：探讨转移性肝癌（MHC）的彩色多普勒血流显像（CDFI）特征。
Objective:To explore the characters of color Doppler flowing imaging(CDFI)of metastatic hepatic cancer(MHC).
目的探讨自制造影剂和超声显像新技术在诊断实验性转移性肝癌血管特征中的应用价值。
Objective To investigate the application of a self made echo contrast agent and power Doppler imaging of ultrasonography on the vascularity of hepatic metastasis in experimental rabbits.
原发性肝细胞癌、转移性肝癌、局灶性结节增生、炎性假瘤在MRSP各期中表现不同。
Primary hepatic carcinoma, hepatic metastases, focal nodular hyperplasia, and inflammatory pseudotumor were presented as different MR features on each phase of MRSP.
结论射频消融治疗具有操作简单、创伤小、恢复快、并发症少等优点，是治疗转移性肝癌的有效方法之一。
Conclusion RFA has virtues of simplicity, light hurt, quick resume and few complications. It is one of the effective methods to treat metastasis liver tumor.
结论用MSCT血管重建和肝动脉、门静脉双重化疗栓塞治疗转移性肝癌有一定临床效果，且无明显毒副作用。
CONCLUSION: Vascular restructure with MSCT and chemoembolization through portal vein and liver artery, with no obvious side-effects, are effective for patients with liver cancer metastases.
结论RFA是治疗原发性及转移性肝癌安全有效的手段，与TACE联合应用更有助于提高对肝癌的治疗效果。
Conclusion RFA is a safe and effective therapy for primary liver cancer and metastasis. RFA combined with TACE can increase the efficacy of liver cancer.
方法利用二维、彩色多普勒超声（CDFI）对42例原发性肝癌（H CC）与58例转移性肝癌（MHC）患者的超声检查。
Methods 42 cases primary hepatocellular carcinoma(HCC) and 58 cases metastatic hepatic cancer(MHC) using two-dimensional Color Doppler Flow Imaging(CDFI).
肝占位病变包括：原发性肝癌29个，转移性肝癌4个，肝血管瘤8个，肝局灶性结节性增生12个，炎性假瘤2个和血管平滑肌脂肪瘤3个。
The final diagnosis of hepatic lesions was 29 primary liver cancers 4 metastases 8 hemangiomas 12 focal nodular hyperplasia 2 inflammatory pseudotumors of the liver and 3 angiomyolipomas.
“转移性肿瘤”，指的是全身其他器官的肿瘤，如：肺癌、肝癌等，转移到眼窝的恶性瘤。
"Metastatic tumor", referring to the other organs of the body tumors, such as: lung, liver, and transferred to the orbital malignant tumor.
结果2 0例中12例确诊为肝癌、1例为转移性肺癌，7例确诊为良性病变。
Results 12 patients were diagnosed as liver cancer, 1 lung metastases, 7 benign mass.
结果2 0例中12例确诊为肝癌、1例为转移性肺癌，7例确诊为良性病变。
Results 12 patients were diagnosed as liver cancer, 1 lung metastases, 7 benign mass.
应用推荐